Clinical Study

Influence of APOE Genotype on Alzheimer’s Disease CSF Biomarkers in a Spanish Population

Table 3

Influence of age on CSF AD variables.

CSF variables Age Number of
patients
Mean ± SDSignificance level Adjusted significance level

Aβ protein
(pg/mL)
≥75
<75
16
40
858.63 ± 457.41
1146.1 ± 444.34
0.03 0.06

T-tau protein
(pg/mL)
≥75
<75
16
40
381.75 ± 172.46
283.18 ± 218.34
0.11 0.38

Median (25–75)

p-tau protein
(pg/mL)
≥75
<75
16
40
59 (52.0–88.68)
40 (42.1–60.15)
0.01 0.21

Ratio
T-tau/Aβ
≥75
<75
16
40
0.42 (0.35–0.74)
0.16 (0.21–0.45)
0.007 0.26

Ratio
p-tau/Aβ
≥75
<75
16
40
0.07 (0.05–0.15)
0.03 (0.04–0.07)
0.004 0.09

Student’s -test. Mann-Whitney test.